Related Experiment Video

Updated: Sep 26, 2025

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.0K

Seroprevalence comparison of different varicella vaccines among Turkish children

BongKyoo Choi1,2, ShiNae Kwon1

  • 1Department of Research and Development, GC Pharma, Yongin, South Korea.

Human Vaccines & Immunotherapeutics
|April 21, 2022
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.6K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.8K

Related Experiment Videos

Last Updated: Sep 26, 2025

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

16.0K
An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.6K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.8K

Related Concept Videos

Vaccinations01:51

Vaccinations

45.4K
Overview
45.4K
Cross-reactivity00:42

Cross-reactivity

31.6K
Overview
31.6K
Prevalence and Incidence01:08

Prevalence and Incidence

865
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
865

Articles linked to this work by shared authors, journal, and citation graph.

Age-group differential trends in the incidence of herpes zoster during 2010-2024 using Korean national healthcare claim data.

Human vaccines & immunotherapeutics·2026

Incidence of Bacille Calmette-Guérin associated lymphadenitis in healthy children: A systematic review and meta-analysis.

Human vaccines & immunotherapeutics·2026

Safety, immunogenicity, and effectiveness of the MAV/06 varicella vaccine: A comprehensive review of a new strain vaccine.

Human vaccines & immunotherapeutics·2026

The Structure of Demand, Control, and Stability-Support Underlying the Job Content Questionnaire (JCQ) 2.0-An Innovative Tool for Assessing Multilevel Work Characteristics.

International journal of environmental research and public health·2025

An International Comparative Reliability and Concurrent Validity Assessment of the Multi-Level Job Content Questionnaire (JCQ) 2.0.

International journal of environmental research and public health·2025

International Empirical Validation and Value Added of the Multilevel Job Content Questionnaire (JCQ) 2.0.

International journal of environmental research and public health·2025

Validation of the behavioural and social drivers of influenza vaccine survey in Australia: Cognitive interviews and psychometric evaluation.

Human vaccines & immunotherapeutics·2026

Adult vaccination coverage and missed preventive care opportunities among Filipino adults with diabetes: A cross-sectional study.

Human vaccines & immunotherapeutics·2026

Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease.

Human vaccines & immunotherapeutics·2026

12th Immunotherapy of Cancer Conference (ITOC12): A meeting report.

Human vaccines & immunotherapeutics·2026

The intrinsic, instrumental, and symbolic values of sustaining childhood vaccination in conflict settings.

Human vaccines & immunotherapeutics·2026

Real-world evaluation of 2023-2024 XBB.1.5 mRNA and protein-based COVID-19 vaccine reactogenicity from the randomized BEEHIVE trial.

Human vaccines & immunotherapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us